NGL sales were USD 12.0 million in the quarter, against USD 7.7 million in the third quarter of 2025. The filing says the company reclassified certain gathering and processing fees from net presentation within natural gas and NGL sales for the 2025 periods, with …
Chief Executive Officer Ron Glibbery said the quarter reflected previously indicated headwinds from irregular order patterns among customers in the fixed wireless access market. He said the company has begun to see early signs of renewed customerDemandin the fourth quarter.
On aGAAPbasis, the company reported a net loss of USD 247.5 million for the quarter, which included a USD 203 million goodwillImpairmentlargely triggered by declines in theMarket Valueof itsEquityand debt.
Quarter-over-quarter changes in net product revenue over the four most recent quarters were increases of 28%, 17% and 45%, followed by the 1% decline in the third quarter. Because theMergerwas effective July 1, 2025, results for the nine months ended September 30, 2026 are …
The filing shows a net loss of USD 49,234 thousand for the quarter, against USD 50,332 thousand a year earlier. For the nine months, the company reportedNet Incomeof USD 26,386 thousand, which includes a gain from the sale of a rare pediatric disease priority …
Chief Financial Officer Joseph Nalepa said the decline in revenue was primarily attributable to high-margin perpetual ALPR software licenses in the public safetyBusinessthat did not occur this year. He said the ALPR market is in a period of transition as customers evaluate evolving privacy …
The company said it acquired theAssetsof Zola in May 2021 and has since offered consumers coconut water products positioned around rehydration. It previously developed products mainly in wheat, commercialized through food sales, trait licensing andRoyaltyagreements.
Management also reported updated Phase 2 results for NDV-01, including initial 18-month data from a long-term extension, and said it renamed its registrational Phase 3 program SPECTRUM.
Total reimbursable costs were USD 422.8 million, against USD 506.9 million in fiscal 2025. Total compensation and benefits expense was USD 174.4 million, against USD 178.5 million, and general and administrative expense was USD 40.9 million, against USD 42.5 million.Equitybased compensation was USD 15.8 …
The company supplies liquid and dry acid and bicarbonate concentrates and other ancillary products used in hemodialysis and serves about 300 customers, including all five of the leading dialysis providers in the United States. Dialysate concentrates and ancillary products accounted for all of its …